Google
WWW ComplianceNet, Inc.
 
 

Auditing Biopharma APIs

 
 

Auditing Biopharma APIs
API GMPs Training
Process Validation
Compliance: Analytical Labs
Compliance: Proc. Development
Part 11 Compliance
Intro to GMPs
API GMPs Overview
Process Val Overview

Home
Consulting Services
Training
About Us
Contact Us
Upcoming Events
FDA News
Warning Letter Hot Topics
Links:  Regulatory and Industry
Document Library
cGMP Defined



 

 

 

 

Auditing and Compliance for Biopharmaceutical APIs 

Approximate Time: 3 days (including class exercises)

Course description: 

This course reviews and interprets the technology and current FDA compliance requirements for the production and testing of biopharmaceutical APIs, and discusses the critical issues to consider when conducting an effective and efficient GMP audit.  Utilizing a risk-based approach to compliance, as part of implementing the FDAs Quality Systems Approach to CGMP, is emphasized.

The topics reviewed during this course include an overview of the technologies and the basic compliance requirements for biopharmaceutical APIs. Applicable FDA guidance in each area will be reviewed and interpreted along with recent regulatory observations. Topics are categorized and presented utilizing the FDAs Six-system Inspection Model. Critical aspects of each system that are specific to biopharmaceutical APIs and should be considered during a successful audit will be highlighted and successful preventive measures and solutions will be discussed.

Class exercises and case studies will help attendees to gain hands on experience in how to apply regulatory interpretations to real life situations. Throughout the course, examples will be used to highlight the points made.  Current industry hot topics will be presented along with an explanation of the associated regulatory concerns.  

Course Topics include:     Detailed Outline
 

bullet

Quality System
bullet

Adequacy of Biopharmaceutical Investigations

 

bullet

Facilities and Equipment System
bullet

Facilities and Equipment: Design for Contamination Control

bullet

Environmental Monitoring and Exceeded Limit Investigations

bullet

Understanding Equipment Cleaning, Sterilization and Sanitization (including CIP and SIP)

bullet

Cleaning Validation/Verification including Multi-product Equipment

bullet

Computerized Systems: Control for Part 11 Compliance

 

bullet

Materials System
bullet

Critical Materials (including Animal Sourced)

bullet

Supplier Qualification

bullet

Master and Working Cell Bank Generation, Characterization and Maintenance

 

bullet

Production System
bullet

Recombinant DNA Technology

bullet

Fermentation/Cell Culture Technology and Processes including Inoculum Preparation, Control Systems and Monitoring

bullet

Harvesting and Recovery Techniques and Processes including Centrifugation, Filtration and Capture Chromatography

bullet

Purification Techniques including Chromatography, Ultrafiltration/Diafiltration, Viral Inactivation/Removal, and Crystallization

bullet

Aseptic Operations in the Biotech Process

bullet

Established Life Span for Chromatography Columns and UF Membranes

bullet

Ongoing Process Monitoring including Bioburden Control

 

bullet

Laboratory System
bullet

Biotech Laboratory Techniques for Identity, Potency and Purity including ELISA, HPLC, DNA, LAL, Electrophoresis, and Cell-based Assays

bullet

Critical Laboratory Systems including Sample Handling, OOS Results, Critical Reagents, and Standards

bullet

API and Intermediate Stability

 

bullet

Packaging and Labeling System
bullet

API Container/Closure Validation

Learning Objectives:

This course will provide the attendees with a basic technical knowledge of biopharmaceutical processes and their support functions and a thorough overview of all related GMP compliance issues.  It will emphasize those issues that are currently gaining significant regulatory attention, as well as those that pose the greatest risk to the safety, identity, strength, quality or purity of the API.

Who should attend:

This course is intended for Quality Assurance and Production biopharmaceutical professionals.  Regulatory Affairs, Research and Development, Quality Control, and Validation professionals involved in the support of biopharmaceutical APIs should also attend.

 

Back to Training

Rates

 

FDA on Training

Once the API starting material is introduced into the API process, manufacturers should increase GMP controls according to some reasonable and scientifically sound rational as processing proceeds from early process steps to final synthesis, isolation and purification steps. Of course, the degree of control depends on the process and manufacturing stage.

Edwin Rivera Martinez, FDA
Presentation at joint PDA/FDA
September 2001


Copyright 2003 Compliance Net, Inc.

Home  |  Contact Us